- Consolidated sales rise 18% to €136.5 million
- Consolidated EBIT grows to €12.0 million (+ 56%)
- Earnings per share (undiluted) are €1.53 (previous year: €0.95)
Fiscal 2007 was a successful year for the euromicron Group. It generated sales of €136.5 million (previous year: €116 million), while its consolidated EBIT was €12.0 million, a year-on-year increase of 56%. The EBIT margin was able to be grown substantially from 6.6% in the previous year to 8.8% in the fiscal year under review thanks to projects with higher margins and lower special expenses for company acquisitions.
We also succeeded in sharply increasing net profit to €7.0 million. Undiluted earnings per share were €1.53, significantly up on the previous year (€0.95).
The buy and build strategy was continued rigorously in 2007. The aim of company acquisitions is and will remain to further expand what is already a clearly structured technology group. The focus in the past year was, as announced, on internationalization – with entry into the Austrian market – and on rounding out the Group’s blanket presence in Germany.
Apart from acquisition activity, a further area of focus was on operational and structural alignment of the existing portfolio. As part of group integration, a key step was taken in system business. In the Southern grouping, the companies Pfeiffer GmbH, NTA GmbH, TBS Telefonbau Schneider GmbH, Krumm Telekom GmbH and o-n-e optical network elements GmbH were merged with each other effective October 1, 2007, and now operate as euromicron solutions GmbH, headquartered in Mainz.
Thanks to strong earnings and business development in 2007, euromicron AG has a solid basis and so is proposing a dividend of €0.80, a year-on-year increase of some 14%.
The share began the year at €21.50 and closed it at €19.00. The share price did not make any advancement during the year due to the general nervousness on the stock markets, where stock in small cap technology companies in particular was sold, regardless of their individual performance.
“With the foundations we have created, further planned structural optimization and stable development in busines activity, we are well positioned to achieve the further milestone of €200 million in sales for the fiscal year 2008,” says Dr. Späth, Chairman of the Executive Board.